MDS Podcast Dystonia Series: Genetic landscape of dystonia
In part 3 of the Dystonia Special Series, Dr. Francesca Morgante interviews Prof. Carolyn Sue on the Genetic landscape of dystonia.
Read MorePodcast: MDS PODCAST: Defining Parkinson's disease
MDS Podcast Clozapine in Parkinson’s disease: Why, when and how?
Clozapine is a antipsychotic drug that has been marketed for decades. In this interview, Dr. Friedman shares his thoughts on its utility in Parkinson’s disease along with some practical advices on how to use it in the clinic. Read the article.
Read MoreMDS Podcast Dystonia Series: Beyond “torsion»: non-motor features of dystonia
In part 2 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Davide Martino on the non-motor features of dystonia.
Read MoreMDS Podcast Off-State Dyskinesias after GDNF Infusion in Parkinson’s Disease
Sara Schaefer speaks to Alan Whone of the University of Bristol on his retrospective analysis of off-state dyskinesias in Parkinson’s disease patients who received serial infusions of GDNF into the putamen. Read the article.
Read MoreMDS Podcast Dystonia Series: Pearls on diagnosis and phenomenology
In part 1 of the Dystonia Special Series, Dr. Francesca Morgante interviews Dr. Miryam Carecchio on pearls on diagnosis and phenomenology of dystonic syndrome.
Read MoreMDS Podcast Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings
Prof Martino points out the existent literature concerning the objective findings in the 3 cardinal domains of idiopathic normal pressure hydrocephalus. Read the article.
Read MoreMDS Podcast History of Movement Disorders: Huntington’s Disease in Venezuela
As part of the History of Movement Disorders series, Dr. Sara Schaefer and Dr. David Standaert discuss the research and humanitarian work by Nancy Wexler and team starting in the 1970s in the Venezuelan village of Barranquitas, which has the highest prevalence of Huntington’s disease in the world.
Read MoreMDS Podcast Deep brain stimulation for Parkinson’s disease dementia: are we there yet?
Dr. Michele Matarazzo interviews Prof. Marjan Jahanshahi on the long term results of the clinical trial of deep brain stimulation of the nucleus basalis of Meynert in people with Parkinson’s disease dementia. In the discussion Prof. Jahanshahi shares thoughts on the future directions of the field. Read the article.
Read MoreMDS Podcast The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders
In this episode, Dr. Hugo Morales Briceño discusses the spectrum of phenotypes and genotypes of children with hyperkinetic movement disorders with Dr. Belén Pérez Dueñas and Prof. Manju Kurian. Read the article.
Read More